Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
May 3 NVO Weight-loss drug competition heats up. Is Wegovy in trouble?
May 3 NVO Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
May 3 NVO Amgen Knocks Novo Nordisk's Ozempic Stock Rally. Its Stock Is Flying.
May 3 NVO FTC Seeks More Information on $16.5 Billion Novo-Catalent Deal
May 3 NVO Catalent, Novo Nordisk receive FTC request for more information
May 3 NVO US FTC seeks more information on Novo Nordisk parent-Catalent deal
May 3 NVO UPDATE 2-US FTC seeks more information on Novo Nordisk parent-Catalent deal
May 3 NVO Job Market Cools In April: Payrolls Miss Forecasts, Wages Rise Less Than Expected
May 3 NVO How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss drugs
May 3 NVO This Is a Huge Sigh of Relief for Novo Nordisk Investors
May 3 NVO Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data
May 3 NVO Novo slides as Amgen fuels obesity drug competition fears
May 3 NVO Here’s How Novo Holdings’ Catalent (CTLT) Acquisition Affects Laughing Water Capital
May 2 PODD Insulet (PODD) Rises Higher Than Market: Key Facts
May 2 NVO Weight Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
May 2 NVO Novo Nordisk slides while Moderna pops: Tale of two pharma stocks
May 2 NVO Market Chatter: Novo Nordisk, Eli Lilly's Weight-Loss Drugs Get Price Cuts in UK
May 2 NVO Weigh Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
May 2 CORT The Analyst Verdict: Corcept Therapeutics In The Eyes Of 4 Experts
May 2 NVO Novo Nordisk (NVO) Q1 2024 Earnings Call Transcript
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags